Source:



Rating:

Share or cite this content

Citations should be made in the following way:
S-E. Dahlén (Stockholm, Sweden). The Innovative Medicines Initiative (IMI), a promising partnership to deliver new medicines to patients. 2008

Member's Comments

No comment yet.

Related content which might interest you: Innovative Medicines Initiatives (IMI) Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014 The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level Source: Eur Respir J 2008; 31: 924-926 Year: 2008 How to assist bringing new drugs to patients: role of the European Medicines Agency Source: International Congress 2019 – Rare lung diseases Year: 2019 Better Medicines for Children - European regulation, European research networks, Funding opportunities Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Health Research collaboration in Europe: an innovative initiative Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP) Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016 Year: 2017 Health care professionals's features of an ideal inhaler in testing new inhaler device. Does it recognize their needs? Source: International Congress 2014 – Medical education: web and internet Year: 2014 Involving patients in developing, refining and testing an implementation strategy to promote asthma self-management using the National Standards for Public Involvement Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019 Medicines for children in Europe: from proposals to practicalities Source: Eur Respir J 2010; 35: 228-229 Year: 2010 Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes  Year: 2016 The ERS European Forum for TB Innovation in Europe: a new way to raise innovation Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013 A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care Source: Eur Respir J 2012; 39: 1220-1229 Year: 2012 Patient's device preference in study of new inhaler. Do patients find the new device user-friendly? Source: International Congress 2014 – Medical education: web and internet Year: 2014 AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation Source: Eur Respir J 2016; 47: 1028-1033 Year: 2016 Collaboration with non-profit organization, EPAREC (Expert Patient in Respiratory Care) in disseminating asthma management plan Source: Eur Respir J 2006; 28: Suppl. 50, 738s Year: 2006 The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers Source: Eur Respir J, 52 (4) 1801665; 10.1183/13993003.01665-2018 Year: 2018 The future of health care. The perspective of the UK Health Policy Makers Source: ERS Summit on priorities in respiratory medicine 2011 Year: 2011 Current and future costs of asthma in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013